As such, the development of optimized Lp(a) transgenic animal models will advance the understanding of the mechanistic role of Lp(a) in atherosclerosis and aortic stenosis [164], as well as in CAS, and provide a platform to examine novel therapies for cardiovascular disease. This evidence concerns the gene LPA and atherosclerosis.